COALITION OF CANCER COOPERATIVE GROUPS

The Coalition of Cancer Cooperative Groups is a research-focused entity dedicated to advancing cancer clinical trials and translational science through collaborative network coordination. Its core capabilities center on designing, managing, and supporting multi-institutional oncology research protocols, integrating data standardization, regulatory compliance, and centralized trial operations across academic and community-based sites. The organization specializes in protocol development, patient accrual strategy, biospecimen management, and real-time data monitoring using standardized oncology endpoints and NCI-aligned frameworks. Key differentiators include deep expertise in cooperative group governance, IRB harmonization, and the operationalization of complex, multi-site clinical research infrastructure under NCI-sponsored initiatives. Technical proficiency spans electronic data capture systems, clinical trial management platforms, and adherence to Good Clinical Practice (GCP) and 21 CFR Part 11 requirements. Award history is not available to infer specific agency relationships or recent contract activity. Consequently, no definitive patterns of engagement with federal departments or funding bodies can be confirmed from the provided data. The primary NAICS code 541690, “Other Scientific and Technical Consulting Services,” reflects its role in providing specialized research coordination and scientific operational support rather than traditional consulting. This places the organization within the biomedical research services sector, with a vertical specialization in oncology clinical research infrastructure and cooperative trial execution. The entity is structured as an 8H—indicating a non-profit organization—and is headquartered in Philadelphia, PA. It holds no government certifications. Its market positioning is anchored in the non-profit biomedical research ecosystem, serving as a backbone for large-scale, investigator-initiated cancer trials, though its direct federal contracting footprint cannot be characterized due to insufficient award data.